Clinical trial
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy Study After Everolimus-eluting Cobalt-chromium Stent-3
NCT04609111 is registered in ClinicalTrials.gov with Kyoto University, Graduate School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ShorT and OPtimal Duration of Dual AntiPlatelet Therapy Study After Everolimus-eluting Cobalt-chromium Stent-3
- Lead sponsor
- Kyoto University, Graduate School of Medicine
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 29, 2021
- Completion date
- December 31, 2025
- Enrollment
- 6,002 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.